Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-002060
Filing Date
2018-03-23
Accepted
2018-03-23 13:24:35
Documents
7
Period of Report
2018-05-02
Effectiveness Date
2018-03-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2234916zdef14a.htm DEF 14A 525242
2 G451289.JPG g451289.jpg GRAPHIC 13600
3 G522065.JPG g522065.jpg GRAPHIC 5222
4 G320907.JPG g320907.jpg GRAPHIC 4718
5 G796392.JPG g796392.jpg GRAPHIC 7126
6 G32612BGI001.GIF g32612bgi001.gif GRAPHIC 97542
7 G32612BGI002.GIF g32612bgi002.gif GRAPHIC 103714
  Complete submission text file 0001047469-18-002060.txt   846587
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35024 | Film No.: 18709498
SIC: 2833 Medicinal Chemicals & Botanical Products